Tomida A - Search Results

1

Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial.

Tomida A, Uehara K, Hiramatsu K, Maeda A, Sakamoto E, Okada Y, Kurumiya Y, Nakayama G, Nakamura M, Aiba T, Nagino M; Of the Nagoya Surgical Oncology Group. Tomida A, et al. Int J Clin Oncol. 2019 Apr;24(4):403-410. doi: 10.1007/s10147-018-1372-6. Epub 2018 Nov 23. Int J Clin Oncol. 2019. PMID: 30471067 Clinical Trial.

2

A 12-mm carcinoid tumor of the minor duodenal papilla with lymph node metastases.

Fukami Y, Kurumiya Y, Mizuno K, Sekoguchi E, Kobayashi S, Ito A, Tomida A, Onishi S, Shirotsuki R, Okubo K, Narita M. Fukami Y, et al. Among authors: tomida a. Jpn J Clin Oncol. 2013 Jan;43(1):74-7. doi: 10.1093/jjco/hys185. Epub 2012 Nov 6. Jpn J Clin Oncol. 2013. PMID: 23136240

3

Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II.

Yun J, Tomida A, Nagata K, Tsuruo T. Yun J, et al. Among authors: tomida a. Oncol Res. 1995;7(12):583-90. Oncol Res. 1995. PMID: 8704275

4

Nuclear localization of proteasomes participates in stress-inducible resistance of solid tumor cells to topoisomerase II-directed drugs.

Ogiso Y, Tomida A, Tsuruo T. Ogiso Y, et al. Among authors: tomida a. Cancer Res. 2002 Sep 1;62(17):5008-12. Cancer Res. 2002. PMID: 12208754

5

Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin.

Tomida A, Naito M, Tsuruo T. Tomida A, et al. Jpn J Cancer Res. 1995 Feb;86(2):224-32. doi: 10.1111/j.1349-7006.1995.tb03043.x. Jpn J Cancer Res. 1995. PMID: 7730148 Free PMC article.

6

Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells.

Kataoka S, Naito M, Tomida A, Tsuruo T. Kataoka S, et al. Among authors: tomida a. Exp Cell Res. 1994 Nov;215(1):199-205. doi: 10.1006/excr.1994.1332. Exp Cell Res. 1994. PMID: 7957669

7

Glucose-regulated stresses induce resistance to camptothecin in human cancer cells.

Tomida A, Yun J, Tsuruo T. Tomida A, et al. Int J Cancer. 1996 Nov 4;68(3):391-6. doi: 10.1002/(SICI)1097-0215(19961104)68:3<391::AID-IJC19>3.0.CO;2-B. Int J Cancer. 1996. PMID: 8903483

8

Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells.

Tomida A, Suzuki H, Kim HD, Tsuruo T. Tomida A, et al. Oncogene. 1996 Dec 19;13(12):2699-705. Oncogene. 1996. PMID: 9000144

9

Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines.

Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T. Yamada M, et al. Among authors: tomida a. Cancer Chemother Pharmacol. 1997;40(1):31-7. doi: 10.1007/s002800050621. Cancer Chemother Pharmacol. 1997. PMID: 9137526

10

Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.

Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T. Yamada M, et al. Among authors: tomida a. Clin Cancer Res. 1996 Feb;2(2):427-32. Clin Cancer Res. 1996. PMID: 9816187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters